169 related articles for article (PubMed ID: 10906161)
1. Retinoic acid reduces glomerular injury in a rat model of glomerular damage.
Wagner J; Dechow C; Morath C; Lehrke I; Amann K; Waldherr R; Floege J; Ritz E
J Am Soc Nephrol; 2000 Aug; 11(8):1479-1487. PubMed ID: 10906161
[TBL] [Abstract][Full Text] [Related]
2. Nuclear (receptor) power: retinoids in rat mesangioproliferative disease.
Wagner J
Nephrol Dial Transplant; 2002; 17 Suppl 9():81-3. PubMed ID: 12386299
[TBL] [Abstract][Full Text] [Related]
3. Effects of retinoids on the TGF-beta system and extracellular matrix in experimental glomerulonephritis.
Morath C; Dechow C; Lehrke I; Haxsen V; Waldherr R; Floege J; Ritz E; Wagner J
J Am Soc Nephrol; 2001 Nov; 12(11):2300-2309. PubMed ID: 11675406
[TBL] [Abstract][Full Text] [Related]
4. Isotretinoin alleviates renal damage in rat chronic glomerulonephritis.
Schaier M; Lehrke I; Schade K; Morath C; Shimizu F; Kawachi H; Grone HJ; Ritz E; Wagner J
Kidney Int; 2001 Dec; 60(6):2222-34. PubMed ID: 11737596
[TBL] [Abstract][Full Text] [Related]
5. Effects of all-trans retinoic acid on renin-angiotensin system in rats with experimental nephritis.
Dechow C; Morath C; Peters J; Lehrke I; Waldherr R; Haxsen V; Ritz E; Wagner J
Am J Physiol Renal Physiol; 2001 Nov; 281(5):F909-19. PubMed ID: 11592949
[TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid receptor alpha and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat.
Schaier M; Liebler S; Schade K; Shimizu F; Kawachi H; Grone HJ; Chandraratna R; Ritz E; Wagner J
J Mol Med (Berl); 2004 Feb; 82(2):116-25. PubMed ID: 14712350
[TBL] [Abstract][Full Text] [Related]
8. Retinoid receptor-specific agonists alleviate experimental glomerulonephritis.
Lehrke I; Schaier M; Schade K; Morath C; Waldherr R; Ritz E; Wagner J
Am J Physiol Renal Physiol; 2002 Apr; 282(4):F741-51. PubMed ID: 11880336
[TBL] [Abstract][Full Text] [Related]
9. Isotretinoin ameliorates renal damage in experimental acute renal allograft rejection.
Kiss E; Adams J; Gröne HJ; Wagner J
Transplantation; 2003 Aug; 76(3):480-9. PubMed ID: 12923432
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis.
Oseto S; Moriyama T; Kawada N; Nagatoya K; Takeji M; Ando A; Yamamoto T; Imai E; Hori M
Kidney Int; 2003 Oct; 64(4):1241-52. PubMed ID: 12969142
[TBL] [Abstract][Full Text] [Related]
11. Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
Panichi V; Migliori M; Taccola D; Filippi C; De Nisco L; Giovannini L; Palla R; Tetta C; Camussi G
Kidney Int; 2001 Jul; 60(1):87-95. PubMed ID: 11422740
[TBL] [Abstract][Full Text] [Related]
12. The renal retinoid system: time-dependent activation in experimental glomerulonephritis.
Liebler S; Uberschär B; Kübert H; Brems S; Schnitger A; Tsukada M; Zouboulis CC; Ritz E; Wagner J
Am J Physiol Renal Physiol; 2004 Mar; 286(3):F458-65. PubMed ID: 14583434
[TBL] [Abstract][Full Text] [Related]
13. Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative.
Daniel C; Ziswiler R; Frey B; Pfister M; Marti HP
Exp Nephrol; 2000; 8(1):52-62. PubMed ID: 10644883
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
[TBL] [Abstract][Full Text] [Related]
15. S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.
Martini S; Krämer S; Loof T; Wang-Rosenke Y; Daig U; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1761-70. PubMed ID: 17356129
[TBL] [Abstract][Full Text] [Related]
16. Effect of Everolimus versus Bone Marrow-Derived Stem Cells on Glomerular Injury in a Rat Model of Glomerulonephritis: A Preventive, Predictive and Personalized Implication.
Zedan MM; Mansour AK; Bakr AA; Sobh MA; Khodadadi H; Salles EL; Alhashim A; Baban B; Golubnitschaja O; Elmarakby AA
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008770
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of matrix metalloproteinases attenuates anti-Thy1.1 nephritis.
Steinmann-Niggli K; Ziswiler R; Küng M; Marti HP
J Am Soc Nephrol; 1998 Mar; 9(3):397-407. PubMed ID: 9513901
[TBL] [Abstract][Full Text] [Related]
18. Nicorandil improves glomerular injury in rats with mesangioproliferative glomerulonephritis via inhibition of proproliferative and profibrotic growth factors.
Sudo H; Hirata M; Kanada H; Yorozu K; Tashiro Y; Serizawa K; Yogo K; Kataoka M; Moriguchi Y; Ishizuka N
J Pharmacol Sci; 2009 Sep; 111(1):53-9. PubMed ID: 19721333
[TBL] [Abstract][Full Text] [Related]
19. Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivo.
Hugo CP; Pichler RP; Schulze-Lohoff E; Pröls F; Adler S; Krutsch HC; Murphy-Ullrich JE; Couser WG; Roberts DD; Johnson RJ
Kidney Int; 1999 Jun; 55(6):2236-49. PubMed ID: 10354272
[TBL] [Abstract][Full Text] [Related]
20. Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat.
Krämer S; Wang-Rosenke Y; Scholl V; Binder E; Loof T; Khadzhynov D; Kawachi H; Shimizu F; Diekmann F; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2008 Feb; 294(2):F440-9. PubMed ID: 18094032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
